Lichen China Ltd. Announces Registered Direct Offering

TL;DR

LICHEN CHINA LTD is doing a direct offering with institutional investors.

AI Summary

Lichen China Limited announced on January 28, 2025, that it entered into a securities purchase agreement for a registered direct offering with certain institutional investors. The filing is a Form 6-K, reporting for the month of January 2025.

Why It Matters

This filing indicates the company is raising capital through a direct offering, which could impact its financial structure and future operations.

Risk Assessment

Risk Level: medium — Direct offerings can dilute existing shareholders and signal potential financial needs or growth strategies.

Key Players & Entities

• Lichen China Limited (company) — Registrant
• January 28, 2025 (date) — Date of securities purchase agreement
• 001-41493 (company) — SEC File Number

FAQ

Key Financial Figures

• $0.00004 — hares”) of the Company, par value $0.00004 per share (the “Shares”), a
• $0.08 — ;Shares”), at a purchase price of $0.08 per share; and (ii) pre-funded warrants
• $0.079 — Warrants”) at a purchase price of $0.079 per Pre-Funded Warrant. January 28 Reg
• $3.4 million — 025. The Company received approximately $3.4 million in gross proceeds from January 28 Regis
• $0.001 — Ordinary Share at an exercise price of $0.001 per share. The Pre-Funded Warrants are
• $50,000 — ect Offering in an amount not to exceed $50,000. The foregoing summaries of the Placem
• $3.4 Million — d “Lichen China Limited Announces $3.4 Million Registered Direct Offering” is fu

Filing Documents

• ea0229370-6k_lichen.htm (6-K) — 26KB
• ea022937001ex4-1_lichen.htm (EX-4.1) — 111KB
• ea022937001ex5-1_lichen.htm (EX-5.1) — 77KB
• ea022937001ex5-2_lichen.htm (EX-5.2) — 19KB
• ea022937001ex10-1_lichen.htm (EX-10.1) — 115KB
• ea022937001ex10-2_lichen.htm (EX-10.2) — 232KB
• ea022937001ex99-1_lichen.htm (EX-99.1) — 8KB
• ex5-1_001.jpg (GRAPHIC) — 8KB
• ex5-2_001.jpg (GRAPHIC) — 9KB
• 0001213900-25-008867.txt ( ) — 612KB

Forward-Looking Statements

Forward-Looking Statements : This report contains forward-looking other Federal securities laws. For example, the Company is using forward-looking statements when it discusses the closings of both December 26 Registered Direct Offering and December 29 Registered Direct Offering. All statements other than statements of historical facts included in this report are forward-looking statements. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on the Company’s current beliefs, expectations and assumptions regarding the future of its business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking predict and many of which are outside of the Company’s control. The Company’s actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking 31, 2023, filed with the Commission on April 4, 2024, and the Company’s other filings with the Commission. The Company undertakes no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise. 3 Exhibit Index Exhibit No. Description 4.1 Form of the Pre-Funde

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Lichen China Limited By: /s/ Ya Li Name: Ya Li Title: Chief Executive Officer Date: January 31, 2025 5

View Full Filing

View this 6-K filing on SEC EDGAR